Rescriptor and Viramune belong to a new class
October 1998
Rescriptor and Viramune belong to a new class...called non-nucleoside reverse transcriptase inhibitors (NNRTIs).
These drugs inhibit the same enzyme as zidovudine...but they work in a different way.
NNRTIs will be used in combination with protease inhibitors...or nucleoside analogs such as zidovudine.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive